| Dr Chanel Beaudoin Cloutier, MD, PHD | |
|
770 Welch Road, Suite 400, Palo Alto, CA 94304 | |
| (650) 723-5824 | |
| (650) 725-6605 |
| Full Name | Dr Chanel Beaudoin Cloutier |
|---|---|
| Gender | Female |
| Speciality | Plastic Surgery |
| Location | 770 Welch Road, Suite 400, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194248153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | A150899 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chanel Beaudoin Cloutier, MD, PHD 251 Swain Way, Palo Alto, CA 94304 Ph: () - | Dr Chanel Beaudoin Cloutier, MD, PHD 770 Welch Road, Suite 400, Palo Alto, CA 94304 Ph: (650) 723-5824 |
News Archive
United Nations Secretary-General Ban Ki-moon at the opening of the U.N. 2008 High Level Meeting on AIDS on Tuesday called on the international community to end discrimination against HIV-positive people, including travel restrictions, describing such practices as "an affront to our common humanity," Xinhuanet reports.
A new discovery from researchers at The University of Texas MD Anderson Cancer Center has clarified the long-established connection between inflammation and pancreatic cancer development.
The American Academy of Dermatology Association (AADA) applauds the decision of the U.S. Senate to substitute a 10 percent federal excise tax on indoor tanning services for the proposed tax on cosmetic procedures in the Senate's health system reform legislation (H.R. 3590, the Patient Protection and Affordability Act of 2009). The indoor tanning tax, as proposed to Senate leadership by the AADA, furthers its goal of promoting wellness and prevention, and removes the harmful unintended consequences associated with a tax on cosmetic surgery procedures.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases.
› Verified 9 days ago
Dr. Lauren Greenberg, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 750 Welch Rd, Suite 117, Palo Alto, CA 94304 Phone: 650-617-9907 Fax: 650-617-9909 | |
Anita Tanniru Mohan, MBBS Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Palo Alto, CA 94304 Phone: 650-723-4000 | |
Rohit Kumar Khosla, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Ali Salim, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 770 Welch Rd, Suite 400 - Stanford Plastic Surgery, Palo Alto, CA 94304 Phone: 650-723-5824 | |
Dr. Orna Fisher, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1795 El Camino Real, Suite 200, Palo Alto, CA 94306 Phone: 650-321-7100 Fax: 702-946-5114 | |
David Mark Kahn, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Palo Alto, CA 94304 Phone: 650-723-4000 |